Business Description
China Isotope & Radiation Corp
ISIN : CNE1000031F4
Share Class Description:
HKSE:01763: Ordinary Shares - Class HCompare
Compare
Traded in other countries / regions
01763.Hong Kong IPO Date
2018-07-06Description
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.69 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 0.36 | |||||
| Debt-to-EBITDA | 1.77 | |||||
| Interest Coverage | 22.26 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 1.4 | |||||
| Beneish M-Score | -2.26 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.7 | |||||
| 3-Year EBITDA Growth Rate | 12 | |||||
| 3-Year EPS without NRI Growth Rate | 5.7 | |||||
| 3-Year FCF Growth Rate | -35.5 | |||||
| 3-Year Book Growth Rate | 3.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.02 | |||||
| 9-Day RSI | 34.65 | |||||
| 14-Day RSI | 39.47 | |||||
| 6-1 Month Momentum % | -10.84 | |||||
| 12-1 Month Momentum % | -30.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.93 | |||||
| Quick Ratio | 1.73 | |||||
| Cash Ratio | 0.68 | |||||
| Days Inventory | 90.4 | |||||
| Days Sales Outstanding | 207.75 | |||||
| Days Payable | 65.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.36 | |||||
| Dividend Payout Ratio | 0.48 | |||||
| 3-Year Dividend Growth Rate | 43.1 | |||||
| Forward Dividend Yield % | 3.36 | |||||
| 5-Year Yield-on-Cost % | 11.86 | |||||
| Shareholder Yield % | -10.12 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 52.48 | |||||
| Operating Margin % | 12.13 | |||||
| Net Margin % | 5.59 | |||||
| FCF Margin % | 1.28 | |||||
| ROE % | 8.12 | |||||
| ROA % | 3.01 | |||||
| ROIC % | 9.34 | |||||
| ROC (Joel Greenblatt) % | 23.1 | |||||
| ROCE % | 11.69 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.05 | |||||
| PE Ratio without NRI | 10.13 | |||||
| PEG Ratio | 1.33 | |||||
| PS Ratio | 0.43 | |||||
| PB Ratio | 0.64 | |||||
| Price-to-Tangible-Book | 0.68 | |||||
| Price-to-Free-Cash-Flow | 35.12 | |||||
| Price-to-Operating-Cash-Flow | 35.12 | |||||
| EV-to-EBIT | 1.91 | |||||
| EV-to-EBITDA | 1.91 | |||||
| EV-to-Revenue | 0.28 | |||||
| EV-to-FCF | 22.02 | |||||
| Price-to-Projected-FCF | 0.27 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.31 | |||||
| Price-to-Graham-Number | 0.55 | |||||
| Earnings Yield (Greenblatt) % | 52.36 | |||||
| FCF Yield % | 2.84 | |||||
| Forward Rate of Return (Yacktman) % | 26.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
China Isotope & Radiation Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 7,257.219 | ||
| EPS (TTM) (HK$) | 1.269 | ||
| Beta | 0.9 | ||
| Volatility % | 26.4 | ||
| 14-Day RSI | 39.47 | ||
| 14-Day ATR (HK$) | 0.259148 | ||
| 20-Day SMA (HK$) | 10.621 | ||
| 12-1 Month Momentum % | -30.16 | ||
| 52-Week Range (HK$) | 9.03 - 16.14 | ||
| Shares Outstanding (Mil) | 319.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
China Isotope & Radiation Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
China Isotope & Radiation Corp Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
China Isotope & Radiation Corp Frequently Asked Questions
What is China Isotope & Radiation Corp(HKSE:01763)'s stock price today?
The current price of HKSE:01763 is HK$10.22. The 52 week high of HKSE:01763 is HK$16.14 and 52 week low is HK$9.03.
When is next earnings date of China Isotope & Radiation Corp(HKSE:01763)?
The next earnings date of China Isotope & Radiation Corp(HKSE:01763) is .
Does China Isotope & Radiation Corp(HKSE:01763) pay dividends? If so, how much?
The Dividend Yield %  of China Isotope & Radiation Corp(HKSE:01763) is 3.36% (As of Today), Highest Dividend Payout Ratio of China Isotope & Radiation Corp(HKSE:01763) was 0.48. The lowest was 0.13. And the median was 0.18. The  Forward Dividend Yield % of China Isotope & Radiation Corp(HKSE:01763) is 3.36%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers